Corbus Pharmaceuticals presented clinical data at the ESMO Congress on July 30, 2025, held in Berlin, following trials conducted in the United States.
1 report, 1 independent
Updated Jul 30
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Corbus Pharmaceuticals presented clinical data at the ESMO Congress on July 30, 2025, held in Berlin, following trials conducted in the United States.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Corbus Pharmaceuticals
company in Norwood, United States
Nothing else this week.
Coverage
Newest first; wire copies grouped- GlobeNewswireCorbus Pharmaceuticals Announces Upcoming Presentation of Dose Expansion Phase 1/2 Clinical Data for its Nectin-4 Targeting ADC CRB-701 at the 2025 ESMO Annual Congress NORWOOD, Mass., July 30, 2025